<DOC>
	<DOCNO>NCT01939990</DOCNO>
	<brief_summary>The purpose study demonstrate safety effectiveness study drug Nebivolol , people suffer high blood pressure Chronic Obstructive Pulmonary Disease ( COPD ) .</brief_summary>
	<brief_title>Safety Study Nebivolol COPD Patients</brief_title>
	<detailed_description>The study would randomize , placebo-controlled trial 60 hypertensive patient document COPD great age 40 .</detailed_description>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>Clinical diagnosis high blood pressure chronic obstructive pulmonary disease ( COPD ) Asthma ; Heart failur ; End stage kidney disease ; acute myocardial infarction , unstable angina , stroke TIA within past year ; Females pregnant , lactate woman childbearing potential use approved method contraception .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
</DOC>